Latvia vs Sur: Measles-containing-vaccine first-dose (MCV1) immunization coverage
Latvia
99.0%
in 2025
Sur
67.0%
in 2025
Latvia rank
1st
Sur rank
1st
Measles-containing-vaccine first-dose (MCV1) immunization coverage over time
- Latvia
- Sur
How they compare
Latvia currently reports 99.0% against 67.0% in Sur, a difference of 32.0%.
That makes Latvia's figure about 1.5 times Sur's.
Across all 26 years both countries report, Latvia has been ahead every year.
Latvia ranks 1st and Sur ranks 1st of 194 countries.
Latvia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Latvia | Sur | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 96.8% | 82.7% | 14.1% | Latvia |
| 2010s | 95.0% | 75.0% | 20.0% | Latvia |
| 2020s | 98.0% | 64.7% | 33.3% | Latvia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher measles-containing-vaccine first-dose (mcv1) immunization coverage, Latvia or Sur?
- Latvia, at 99.0% against 67.0% in Sur as of 2025.
- What is the difference in measles-containing-vaccine first-dose (mcv1) immunization coverage between Latvia and Sur?
- 32.0%, with Latvia ahead.
- How many years of comparable data are there for Latvia and Sur?
- 26 years are reported by both, from 2000 to 2025.
- How do Latvia and Sur rank globally for measles-containing-vaccine first-dose (mcv1) immunization coverage?
- Latvia ranks 1st and Sur ranks 1st of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Measles-containing-vaccine first-dose (MCV1) immunization coverage among 1-year-olds (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.